Lisinopril and NSAIDs (Ibuprofen, Naproxen): Drug Interaction Guide

Lisinopril is an ACE (angiotensin-converting enzyme) inhibitor approved for hypertension, heart failure, and certain post-heart-attack indications. Common oral NSAIDs (nonsteroidal anti-inflammatory drugs) that patients ask about include ibuprofen (Advil, Motrin) and naproxen (Aleve), plus prescription options such as celecoxib. These are two separate drug classes with a well-documented pharmacodynamic interaction, not a pharmacokinetic one: they act on the same kidney and blood-pressure pathways rather than changing each other's blood levels.

The direct answer: combining lisinopril with a regularly dosed NSAID can reduce lisinopril's blood-pressure-lowering effect, reduce kidney blood flow, and raise serum potassium, with the highest risk in older adults, people with reduced kidney function, heart failure patients, and anyone also taking a diuretic. Occasional, short-course, low-dose NSAID use is a different risk category than daily or multi-week use, and acetaminophen is generally the preferred non-NSAID option for pain when it is medically appropriate. This is an established pharmacodynamic interaction supported by decades of clinical and observational data, but exact magnitude estimates (how many mmHg, what percent increase in kidney injury) vary across studies and should not be treated as fixed numbers for an individual patient.

Why lisinopril and NSAIDs interact

Lisinopril lowers blood pressure and protects the kidney partly through effects on angiotensin II, which normally constricts the efferent (outflow) arteriole of the glomerulus. When angiotensin II is suppressed, the kidney partly compensates by using prostaglandins to keep the afferent (inflow) arteriole dilated, preserving filtration pressure. NSAIDs block the cyclooxygenase (COX) enzymes that make those prostaglandins. Take the two together and the kidney loses one of its main ways to protect filtration pressure, particularly when renal blood flow is already reduced (dehydration, older age, heart failure, chronic kidney disease).

This mechanism is well established pharmacologically and is reflected in FDA prescribing information for ACE inhibitors, which notes that NSAIDs may further impair renal function in patients whose renal perfusion is already compromised.

Does an NSAID make lisinopril less effective?

Blood pressure blunting from NSAIDs, particularly indomethacin and other long-acting or highly COX-selective agents, has been reported in clinical studies going back to the 1990s. Ibuprofen and naproxen have shown smaller but still clinically relevant effects in some trials. A commonly cited estimate is an average increase of a few mmHg in blood pressure during regular NSAID use in patients on antihypertensives, though the size of the effect varies by NSAID, dose, and duration, and by how well-controlled the patient's blood pressure was beforehand. If a patient's blood pressure is already borderline, even a modest rise could move them across a clinically meaningful threshold, such as the 140/90 mmHg cutoff the 2017 ACC/AHA hypertension guideline uses to define stage 2 hypertension.

What is not established: a precise, universal mmHg number that applies to every patient, every NSAID, and every dose. Treat any single-number estimate (including ones you may see elsewhere) as an average from specific study populations, not a guarantee for an individual.

Kidney risk: what the evidence actually shows

The combination of an ACE inhibitor and an NSAID has been studied in large observational (not randomized) datasets, most notably work examining the so-called "triple whammy" combination of an ACE inhibitor or ARB, a diuretic, and an NSAID together. Observational studies in this area have generally found:

• Higher rates of acute kidney injury when NSAIDs are added to ACE inhibitor therapy, especially in the first weeks of concurrent use
• Additional risk when a diuretic is also present (the triple whammy), because diuretics reduce circulating volume on top of the other two mechanisms
• Risk that rises with NSAID dose and duration, and falls off once the NSAID is stopped

These are observational associations from large prescription-database studies, which can show strong signals but cannot fully rule out confounding (for example, sicker patients may be more likely to receive both a diuretic and an NSAID). The exact relative-risk figures reported in this literature vary by dataset and study design; a specific percentage increase should be verified against the original paper rather than quoted as a fixed fact, and that verification has not been completed for this draft.

Who is at greatest kidney risk

• Adults over 65
• Anyone with baseline eGFR below 60 mL/min/1.73m²
• People with diabetes
• People with heart failure
• Anyone also taking a diuretic (the triple whammy scenario)
• Anyone who is dehydrated, vomiting, or has diarrhea, since volume depletion sharply raises the risk

Patients with eGFR below 30 mL/min/1.73m² are generally advised to avoid NSAIDs altogether, independent of what other medications they take; this should be confirmed with a prescriber or pharmacist for the individual's situation.

Hyperkalemia: the less-discussed risk

Lisinopril reduces aldosterone activity, which lowers the kidney's ability to excrete potassium. NSAIDs independently reduce renal blood flow and can further impair potassium handling. The combination has been associated with a higher rate of clinically significant hyperkalemia (high potassium) in observational cohorts, particularly in people already at risk: those with reduced kidney function, diabetes, or additional potassium-raising medications (potassium-sparing diuretics, potassium supplements, trimethoprim).

A reasonable clinical practice, consistent with general nephrology teaching rather than a single specific trial, is to check serum potassium at baseline and again roughly one to two weeks after starting regular NSAID use in a patient on lisinopril, and sooner if the patient has additional risk factors. Potassium above the mid-5 mEq/L range typically prompts stopping the NSAID and rechecking promptly; the exact threshold and timing should come from the prescriber managing the patient, not from this article.

Are some NSAIDs worse than others?

• Ibuprofen has a short half-life (a few hours), so its effects clear relatively quickly after the last dose, but frequent daily dosing can produce sustained COX inhibition similar to a longer-acting drug.
• Naproxen has a longer half-life (roughly half a day), which means more sustained COX inhibition per dose and slower washout if a problem develops.
• Celecoxib and other COX-2-selective NSAIDs cause fewer gastrointestinal ulcers than nonselective NSAIDs in some trial populations, but their effects on blood pressure and renal blood flow with ACE inhibitors appear broadly similar to nonselective NSAIDs; celecoxib is not a "safe" substitute for the cardiorenal interaction, only for GI risk.
• Topical NSAIDs (such as diclofenac gel) produce much lower systemic drug exposure than oral NSAIDs and are generally considered lower risk for this particular interaction, though "lower risk" is not the same as "no risk," especially with extensive or prolonged application.
• High-dose aspirin (above roughly 325 mg/day, used as an analgesic or anti-inflammatory) behaves like an NSAID for this interaction. Low-dose aspirin (81 mg/day) used for cardiovascular prevention is generally not considered a meaningful contributor to this interaction, though it carries its own bleeding and GI considerations that a prescriber should weigh separately.

Evidence-status assessment: lisinopril plus NSAIDs

Safer use, when an NSAID is genuinely needed

Short NSAID courses for dental work, an acute sprain, or postoperative pain are sometimes reasonable even for people on lisinopril, particularly if kidney function is normal and the person is not also on a diuretic. General, non-individualized guidance that is consistent with the mechanism above:

• Use the lowest effective dose for the shortest reasonable time
• Favor ibuprofen over naproxen if an NSAID is needed short-term, because of its shorter half-life and faster washout, if there is no other reason to prefer one drug
• Stay well hydrated during the NSAID course
• Have kidney function and potassium checked if use extends beyond a few days, if the person has any of the risk factors above, or if the prescriber recommends it
• Contact a clinician promptly for decreased urination, new swelling, unusual fatigue, nausea, or a rapid unexplained weight gain, these can be early signs of fluid retention or reduced kidney function and warrant urgent evaluation rather than waiting for a scheduled check

This is general education, not an individualized dosing plan. Anyone with heart failure, chronic kidney disease, or who is also taking a diuretic should not self-manage an NSAID decision and should check with the prescriber first.

Safer alternatives for pain relief

Acetaminophen (Tylenol) does not inhibit renal prostaglandin synthesis in the way NSAIDs do and is generally considered the first-line non-NSAID analgesic option for people on ACE inhibitors, subject to normal acetaminophen dosing limits and liver-related precautions. Total daily acetaminophen intake should stay within the limits on the product label or as directed by a clinician, especially for people with liver disease or heavy alcohol use.

Topical NSAIDs (diclofenac gel) offer localized anti-inflammatory effect with substantially lower systemic absorption than oral NSAIDs, making them a reasonable option for localized joint or muscle pain in many patients on lisinopril, though the interaction is not eliminated entirely with extensive use.

Non-NSAID options for more significant pain (such as short courses of other analgesic classes, or procedures like a corticosteroid injection for a specific joint) may be appropriate in some situations and should be discussed with the prescribing clinician rather than chosen independently.

Special populations

Older adults. Age-related decline in kidney reserve means the prostaglandin-dependent compensation NSAIDs interfere with is already reduced. Combining NSAIDs with ACE inhibitors in older adults with chronic kidney disease is flagged as a combination to generally avoid in geriatric prescribing guidance.

Heart failure. In heart failure, renal perfusion is often already reduced and volume status is more precarious. Current heart failure guideline documents from cardiology societies generally advise avoiding NSAIDs in this population because of the risk of fluid retention and decompensation.

Chronic kidney disease. Below an eGFR of roughly 30 mL/min/1.73m², NSAIDs are generally avoided regardless of what other medications a person takes. Between roughly 30 and 60 mL/min/1.73m², even a brief NSAID course warrants closer monitoring of creatinine.

What is established, what is plausible, and what is not established

Established: NSAIDs and ACE inhibitors act on overlapping kidney and blood-pressure pathways; this interaction is described in FDA prescribing information and is a standard part of clinical pharmacology teaching. Regular, sustained NSAID use in someone on lisinopril carries a real, mechanistically explained risk of reduced blood-pressure control, reduced kidney function, and elevated potassium, with risk concentrated in older adults, those with reduced kidney function, heart failure patients, and people also taking a diuretic.

Plausible but not fully quantified for an individual: exactly how many mmHg a given NSAID will raise a given patient's blood pressure, and exactly how much a given short course raises that patient's kidney injury or hyperkalemia risk. Population-level observational studies show clear directional signals, but the numbers move between studies and populations.

Not established: that any single NSAID (including celecoxib) is free of the renal and blood-pressure interaction, that a fixed universal cutoff (a specific number of days or a specific milligram dose) is safe for every patient, or that this article can tell an individual patient what dose or duration is safe for them. Those decisions require the prescriber or pharmacist managing the person's kidney function, blood pressure, and other medications.

How to talk with a prescriber or pharmacist

• Name the specific over-the-counter products you use or are considering (Advil, Motrin, Aleve, store-brand ibuprofen or naproxen), since many patients do not connect brand names to the NSAID class
• Ask what your baseline creatinine, eGFR, and potassium are, and whether you need repeat labs if you use an NSAID
• Ask specifically whether you are also on a diuretic, since that changes the risk calculation
• If you have heart failure or reduced kidney function, ask whether any NSAID use, even short-term, is appropriate for you
• Ask what your prescriber would want you to use instead, by name, for common pain such as headache, muscle strain, or dental pain